Total lipid extracts of erythrocyte cell membranes from 60 patients with documented malignancies, 41 patients with various acute and chronic diseases, and 40 healthy subjects were analysed. The results were expressed as ratios of stearic to oleic acid, reflecting the diegree of desaturation of stearic acid. The mean ratios for the healthy subjects and controls without cancer were 1-5 (SD 0 27) and 1 45 (0 28), respectively, whereas the ratios for patients with malignancies were consistently lower than the cut off point of 1-0, with a mean of 0 69 (0-15) (p <0 001). The desaturation ratio was also significantly lower (p <0 001) in the group with recurrent tumours (mean 0 75 (0 04)) compared with those with no evidence of recurrent tumours (mean 1-55 (0 27)).
Introduction
The physical properties of lipids depend on the length of the chain and the degree of desaturation of the constituent fatty acids. A higher content of unsaturated fatty acids increases fluidity of cell membranes, which in turn increases the metabolic rates of many cellular enzymes.i 2 It was shown recently that viruses, interferon, and diphtheria toxin can modulate the saturation of the 18 carbon (C18) fatty acids, especially the conversion of stearic to oleic acid. Interferon,3 diphtheria toxin,4 and Sindbis5 and Coxsackie viruses6 inhibit desaturation of stearic acid, whereas viruses that induce fusogenic syncytianamely, Newcastle disease virus, herpes simplex type 2, and a putative interferon antagonist3 -promote it. Previous work has shown a consistently higher content of oleic acid relative to stearic acid in the peripheral red blood cells of patients with chronic leukaemia compared with that in normal blood cells. 7 This study assesses the fatty acid saturation index of red blood cell membranes in patients with various solid tumours.
Subjects, materials, and methods
To determine the saturation index of human erythrocytes in states of health and disease, the ratio of stearic to oleic acid was measured in 146 subjects (table) . Forty were healthy and formed the reference group. Forty one patients with various non-malignant conditions were tne control group. The group with benign tumnours included five patients with benign colorectal polyps. The group with cancer comprised 60 patients, who had the following tumours: colorectal (18), pancreatic (10,) primary hepatocellular carcinoma (10), cholangiocarcinoma (nine), breast (nine), ovarian (one), squamous cell carcinoma (one), abdominal (one), neuroblastoma (one). The various conditions in the control group included: Crohn's disease (two cases), diverticular disease (two), ulcerative colitis (two), perforated duodenal ulcer (two), cholecystitis (two), sclerosing cholangitis (two), pancreatitis (one), cholelithiasis with jaundice (one), primary biliary cirrhosis (one), varicose veins (five), breast abscess (two), fibroadenosis (eight), We used a 2 1 mm x2 m column of 30' SP-2310/2°' SP-2300 to analyse fatty acids because it separates the C18 fatty acids efficiently. As in previous work with viruses and interferon the only consistent change was in the values of oleic and stearic acid. We took the ratio of stearic to oleic acid as the desaturation index because the normal metabolic flow is the irreversible conversion of stearic to oleic acid by desaturation. Erythrocytes were studied because they are end cells incapable of lipid metabolism. Figure 1 shows that the mean saturation index for C18 fatty acids was 1-5 (0 27) in the reference group and 1-45 (0-28) in the control group. The saturation index was above 10 in all but five patients, of whom three were jaundiced with chronic liver conditions (two with sclerosing cholangitis, one with cirrhosis) in which substantial tissue regeneration or undetected precancerous lesions were suspected. Of the two remaining patients, one had hypercholesterolaemia and the other fibroadenosis of the breast. In all the patients with documented malignancies, however, the index was without exception below 10. The mean saturation index in patients with cancer was 0 69 (0-15).
The standard error of difference between the means of the ratio of the control and cancer groups was 0 048. The probability of difference between the means was 15 8 (p < 0 001).
The comparison of patients with recurrent tumours with those who had been treated successfully and were free from malignant disease was more significant (figure 2). In all patients with recurrent tumours the index was below 1-0 (mean 0-75 (0 04); n=7), whereas in all patients who had successful surgical treatment the index remained above 1 0 (mean 1955 (0.27); n = 9, p < 0001). This group included one patient in whom the index before surgical treatment was 0-6, and four months after radical excision of the tumour the value rose to 1 4.
Group with gynaecomastia (one), hernia (three), hypercholesterolaemia (three), chest pain (four).
We also compared the saturation index in a further nine patients, who underwent curative surgery for cancer and were alive and well without any signs of recurrent tumour at the time of taking blood samples, with that in seven patients whose tumours recurred after radical surgical excision of the primary tumours.
A 5 ml blood sample was collected from all patients and centrifuged at 1000 rpm to precipitate red blood cells. Total lipid extraction was carried out with the method described by Apostolov IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy
A study was performed to assess the prevalence of specific antibodies to human T cell lymphotropic retrovirus (HTLV-Ill) in patients with lymphadenopathy syndrome, patients with the acquired immune deficiency syndrome (AIDS), and those at risk of AIDS. Serum samples were obtained from these groups and from healthy controls in selected cities in Italy, and antibodies to HTLV-Ill were measured by immunofluorescence assay and, in a few patients, by Western blotting. In addition, IgM antibody values were measured in 82 of those positive for HTLV-IU. Altogether, 235 out of 320 patients with lymphadenopathy syndrome had antibodies to HTLV-III, the proportions being highest in haemophiliacs, homosexuals, and drug addicts from Rome; 11 out of 12 patients with AIDS had antibodies; 78 out of 439 subjects at risk for AIDS had antibodies; and six out of 30 patients with lymphadenopathy syndrome and positive for HTLV-Ill antibodies and nine of 52 patients at risk of AIDS had a detectable titre of IgM.
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